SAFECODE DRUG TECHNOLOGIES CORP. — Operating Income by Fiscal Year
3 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/95f1b19e-d8c4-4914-a4b2-4a5af4597206/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2013 | $-2.8M | 2010-11-23 – 2013-06-30 | evidence 0001558891-13-000165 |
| FY 2012 | $-2.6M | 2010-11-23 – 2013-03-31 | evidence 0001144204-13-027665 |
| FY 2011 | $-60.1k | 2010-11-23 – 2012-03-31 | evidence 0001144204-12-028867 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).